Search Form
First, enter a politician or zip code
Now, choose a category

Ron Wyden's Public Statements on Issue: Drugs

Office: U.S. Senate (OR) - Sr, Democratic
Date Title
Feb. 17, 2017 Letter to the Hon. Jean-Claude Junker - Regarding European Union Support to Combat the Fentanyl Crisis
Dec. 1, 2016 Letter to the Hon. Paul Ryan, Speaker of the House, the Hon. Mitch McConnell, Senate Majority Leader; the Hon. Nancy Pelosi, House Minority Leader and the Hon. Harry Reid, Senate Minority Leader - Call for Passage of Foster Care Reforms
Nov. 15, 2016 Opioid Addiction
Oct. 26, 2016 Letter to the Honorable Loretta E. Lynch, Attorney General of the United States - Leahy Presses Administration to Take On Opioid Distributors
Oct. 14, 2016 Letter to Mr. Werner Sipp, President, International Narcotics Control Board - Take Action to Regulate Fentanyl
Oct. 13, 2016 Letter to Mr. Werner Sipp, President of the Intl. Narcotics Control Board - Call on UN to Take Action to Regulate Precursor Chemicals of Fentanyl
Oct. 12, 2016 Wyden Report: Opioid Funds Lacking, Nationwide Epidemic Will Continue to Rage
Oct. 10, 2016 Wyden Report Shows Only 1 in 10 Oregonians with Opioid Addiction Receiving Needed Treatment
Oct. 7, 2016 Wyden Statement on Mylan Settlement
Sept. 30, 2016 Wyden, Booker, Gillibrand Express Concern about DEA Process to Schedule Kratom
Sept. 28, 2016 Wyden, Pallone Confirm EpiPen Makers Overcharged Medicaid for Two Decades
Sept. 5, 2016 Washington Post - A Better Way to Help Vulnerable Children and Families
Aug. 11, 2016 Wyden: Federal Law "Behind the Times' with DEA Decision Not to Reschedule Marijuana
July 27, 2016 Wyden Alarmed By Dramatic Rise of Illicit Fentanyl
July 14, 2016 The Family First Prevention Services Bill
July 14, 2016 Murray, Wyden, Leahy, Shaheen Continue Work on Opioid Epidemic, Introduce Legislation to Fund Needed Treatment & Recovery Efforts
July 14, 2016 Letter to Mitch McConnell, Majority Leader of the United States Senate - As Congress Clears Comprehensive Addiction and Recovery Bill, Reed Calls for Emergency Funding for Opioid Epidemic
July 13, 2016 Wyden Statement on Passage of CARA Opioid Legislation
July 13, 2016 Federal Aviation Administration Reauthorization Act of 2016
July 13, 2016 Letter to The Honorable Mitch McConnell. Majority Leader, United States Senate - Commit to Passing Real, Immediate Funding to Fight Opioid and Heroin Epidemic and Actually Carry Out Programs Authorized in CARA Bill
July 6, 2016 Wyden Disappointed in Multi-Million Dollar Windfall for Drug Makers Instead of Care for Pregnant Women in Opioid Conference Report
July 5, 2016 Letter to the Honorable Fred Upton, Chairman of the Committee on Energy and Commerce - Refusal to Sign Opioid Conference Report Without Funding to Combat Drug Addiction Epidemic
July 1, 2016 Letter to Dr. Victoj J. Dzau, M.D., President, National Academy of Medicine - Concerns Regarding National Academy Committee Ties to Opioid Manufacturers
June 23, 2016 Letter to The Honorable Loretta E. Lynch, Attorney General, U.S. Department of Justice, and The Honorable Chuck Rosenberg, Acting Administrator, Drug Enforcement Administration - Requesting Update on Federal Marijuana Rescheduling Decision
June 16, 2016 Finance Senators Introduce Family First Prevention Services Act
June 15, 2016 Letter to Chuck Rosenberg, Acting Administrator of the Drug Enforcement Administration - Request for Information on Surge of Illegally-Produced Fentanyl
June 10, 2016 Bipartisan House, Senate Leaders Announce Proposed Child Welfare Legislation
May 20, 2016 Letter to Gil Kerlikowske, Commissioner and Border Patrol - Concerns on the Dangers of Powerful Opioid Fentanyl
April 27, 2016 Wyden Proposes Cap on Prescription Drug Costs
April 15, 2016 Letter to the Honorable Barack Obama, President of the United States - Call to Remove Barriers to Research on Medical Marijuana
March 10, 2016 Comprehensive Addiction and Recovery Bill
March 2, 2016 Comprehensive Addiction and Recovery Act of 2015
Feb. 29, 2016 Opioid Addiction
Feb. 23, 2016 Hearing of the Senate Committee on Finance - Opening Statement of Sen. Ron Wyden - Hearing on Opioids
Dec. 21, 2015 Letter to Sylvia Mathews Burwell, Secretary of the Department of Health and Human Services, Michael Botticelli, Director of the Office of National Drug Control Policy, and Chuck Rosenberg, Acting Adminstrator of the Drug Enforcement Administration - Medical Marijuana Research
July 29, 2014 Hearing of the Senate Finance Committee - Tobacco: Taxes Owed, Avoided, and Evaded
April 1, 2014 Letter to John J. Manfreda, Alcohol and Tobacco Tax and Trade Bureau - Oregon Delegation Calls for Common Sense Rules for Wine Growlers
Nov. 1, 2012 Wyden, Roe Seek Justice Department Investigation into Pseudoephedrine Tracking Program
July 28, 2011 Sens. Casey, Toomey and Wyden Introduce Bipartisan Bill to Encourage Treatments for Rare Diseases
July 21, 2011 Letter to Dr. Margaret A. Hamburg, Commissioner, Food and Drug Administration
July 13, 2011 Brown, Wyden, McCain Introduce Affordable Medicines Utilization Act Of 2011
July 12, 2011 Brown, Wyden, McCain Introduce Affordable Medicines Utilization Act Of 2011
June 16, 2011 Letter to The Honorable Margaret Hamburg, Commissioner, Food and Drug Administration
Feb. 22, 2011 Letter to The Honorable Daniel Inouye, Chairman of the Senate Appropriations Committee
Dec. 10, 2010 Statements on Introduced Bills and Joint Legislation
Jan. 15, 2010 Wyden Legislation Would Take Oregon Anti-Meth Legislation Nationwide, Require Doctor's Prescription for Pseudoephedrine
April 2, 2009 Hearing of the Senate Finance Committee - The Nomination of Governor Kathleen Sebelius (D-KS) to be Secretary of Health and Human Services
March 25, 2009 Hearing of the Senate Judiciary Committee - Oversight of the Federal Bureau of Investigation (FBI)
March 17, 2009 Panel I Of A Joint Hearing Of The Crime And Drugs Subcommittee Of The Senate Judiciary Committee And The Senate Caucus On International Narcotics Control
Sept. 18, 2008 Tax Extenders
Skip to top

Help us stay free for all your Fellow Americans

Just $5 from everyone reading this would do it.

Back to top